A question for physicians and immunologists: what are the mechanisms for the immune

1,285 Views | 3 Replies | Last: 3 yr ago by Derrida
Derrida
How long do you want to ignore this user?
systems response to both SARS-Cov-2 and the various vaccines.

I am having a discussion with someone about the human immunological response to SARS-Cov-2.

The discussion is over which is better, the post infection immunity or vaccine induced immunity. He believes the Israelis study as well as the Qatar study show that post infection immunity is better and more long standing than vaccine induced immunity.

That's contrary to most other vaccines, except mumps, where vaccine induced immunity is more even and of higher quality.

Here is his explanation. Tell what I'm missing.

"When an individual is exposed to a respiratory pathogen, the first line of defense is IgM mucosal immunity. A vaccinated person typically does not get this immunity, because the antibodies are first encountered in the bloodstream, not external mucosal linings. This is one reason why vaccinated individuals tend to have as much antigen on their mucosal swabs as unvaccinated, previously uninfected individuals and more than a naturally immune person. Hence, they can still be vectors of disease through mucosal spread.

The second line of defense is humoral immunity. This is what we also know of as IgG antibody induced immunity. Antibodies are created in order to defeat the acute illness. It takes a while for the human body to ramp up those antibodies from scratch, so during that time a patient is ill. The current Covid vaccine appears to do a decent job of inducing humoral immunity (hence the lessening of symptoms upon subsequent exposure to the live virus). However, this humoral immunity is primarily targeted toward the alpha spike protein, not the other variants. Therefore, we see a lot more breakthrough infections in vaccinated people than we do in naturally immune people, because naturally immune individuals (as with traditional dead/attenuated viral vaccines) were exposed to the entirety of the virus, not just the specific alpha spike protein. This may also be one reason why forthcoming vaccines like Novavax, which use more traditional technology, are thus far proving to be more effective in trials.

The third line of defense is where our long-term immunity comes from, specifically cell-mediated immunity. Over time, circulating antibodies in the bloodstream naturally decline (which is why the argument that we don't know how long antibodies last is irrelevant - they aren't supposed to circulate forever). This is our memory T- & B-cells, killer T-cells, etc. During the first exposure, memory cells are created. Subsequent exposures to the same antigen stimulate these cells to immediately attack the antigen/infected cell & produce antibodies, neutralizing the virus before it can cause symptoms. It is as yet somewhat unclear as to why the current vaccines require boosters and fail to be very productive beyond 3-6 months. One theory is that these vaccines, while doing a fairly adequate job of inducing temporary humoral immunity, do not do as well at stimulating long term cell-mediated immunity; this may be due to the fact that the immune system is not being exposed to the entire virus. In a natural immune response, however, these T cells are stimulated and, for the vast majority of pathogens and how we have understood the immune system to work for decades now, cell-mediated immunity usually lasts a lifetime in a healthy individual."

There are small aspects of his explanation that don't jive with my understanding. Enlighten me please.


TXTransplant
How long do you want to ignore this user?
I can't answer all your questions, but just a correction about the Novavax vaccine. It does not use the Covid virus.

It uses a baculovirus that has been modified to express the spike protein. This baculovirus is then used to infect moth cells, where the virus replicates and makes more of the protein. That protein is then recovered, purified, and used to make the vaccine.

This is called a subunit protein vaccine. Subunit protein vaccines do not use live, attenuated, or deactivated versions of the virus of interest.

The protein is the same as the protein produced in your body using the mRNA vaccines and the J&J adenovirus vaccine.

So, regardless as to whether or not that theory is correct, it has nothing to do with the Novavax vaccine and how it works.
Derrida
How long do you want to ignore this user?
TXTransplant said:

I can't answer all your questions, but just a correction about the Novavax vaccine. It does not use the Covid virus.

It uses a baculovirus that has been modified to express the spike protein. This baculovirus is then used to infect moth cells, where the virus replicated and makes more of the protein. That protein is then recovered, purified, and used to make the vaccine.

This is called a subunit protein vaccine. Subunit protein vaccines do not use live, attenuated, or deactivated versions of the virus of interest.

The protein is the same as the protein produced in your body using the mRNA vaccines and the J&J adenovirus vaccine.

So, regardless as to whether or not that theory is correct, it has nothing to do with the Novavax vaccine and how it works.
Thank you.
Ranger222
How long do you want to ignore this user?
AG
Derrida said:


"When an individual is exposed to a respiratory pathogen, the first line of defense is IgM mucosal immunity. A vaccinated person typically does not get this immunity, because the antibodies are first encountered in the bloodstream, not external mucosal linings. This is one reason why vaccinated individuals tend to have as much antigen on their mucosal swabs as unvaccinated, previously uninfected individuals and more than a naturally immune person. Hence, they can still be vectors of disease through mucosal spread.

This paragraph is completely wrong. IgM is not the "first line of defense for mucosal immunity". That would be IgA. IgA is ~15% of total antibodies produced and present at mucosal sites...like mucus, saliva, etc. and would be the true first line of defense for a respiratory pathogen (bacteria or virus). IgA has been shown to be produced by vaccinated individuals with antibodies that neutralize SARS-COV-2. I think you're friend is mixing up the order in which these antibodies are produced by the body and the "first line of defense" thing. It is true that IgM is the first antibody produced by the body in response to an antigen, that then class switches into IgG and IgA at a later time. IgM is also typically only found in the blood due to their large size...but this is how the immune system works for everyone. The same process occurs for vaccinated vs un-vaccinated people in response to a vaccine or real virus (antigen), so I'm failing to see the point of this as its no different between populations. And the "vaccinated individuals have as much antigen" thing is weird. If two people are exposed to the same amounts of virus, of course they "have as much antigen" no matter if they are vaccinated or not. That's exposure! What matters is does that virus and virus particle then replicate in that person and can the virus be released in a way that leads to infection of another individual. We'd like to believe that vaccinated individuals do not as efficiently replicate and release virus as un-vaccinated individual, but that data is still being collected. The uninfected and naturally immune person having "less antigen" is completely bogus and would require a citation to determine where that statement comes from.

The second line of defense is humoral immunity. This is what we also know of as IgG antibody induced immunity. Antibodies are created in order to defeat the acute illness. It takes a while for the human body to ramp up those antibodies from scratch, so during that time a patient is ill. The current Covid vaccine appears to do a decent job of inducing humoral immunity (hence the lessening of symptoms upon subsequent exposure to the live virus). However, this humoral immunity is primarily targeted toward the alpha spike protein, not the other variants. Therefore, we see a lot more breakthrough infections in vaccinated people than we do in naturally immune people, because naturally immune individuals (as with traditional dead/attenuated viral vaccines) were exposed to the entirety of the virus, not just the specific alpha spike protein. This may also be one reason why forthcoming vaccines like Novavax, which use more traditional technology, are thus far proving to be more effective in trials.

This is all, in theory, true. I was very skeptical of mRNA-based vaccines when the pandemic began for this reason -- exposure to all viral proteins is better than one (spike) to mount an antibody response. However, as we have found, the mRNA vaccines are incredibly successful! The spike protein is a great antigen to make antibodies against! We got incredibly lucky in that regard. In this particular case (may not be true of all viruses / pathogens), it turns out that all we needed was the spike protein and exposure to other viral proteins doesn't really "increase" our immunity in a significant way. The best case for this point is in studies conducted in 2020 looking at the serum of patients that had been infected and recovered from SARS-COV-2 (all pre-vaccine) that determined what type of antibodies these people had. Turned out a large majority, and the best neutralizing antibodies, were all to the spike protein! There is a reason almost all monoclonal antibodies made by companies as IV treatments (like "the Regeneron") are to spike protein and not other proteins. These are the best antibodies and they all bind / recognize spike and are all naturally made/selected for by our own bodies!

The third line of defense is where our long-term immunity comes from, specifically cell-mediated immunity. Over time, circulating antibodies in the bloodstream naturally decline (which is why the argument that we don't know how long antibodies last is irrelevant - they aren't supposed to circulate forever). This is our memory T- & B-cells, killer T-cells, etc. During the first exposure, memory cells are created. Subsequent exposures to the same antigen stimulate these cells to immediately attack the antigen/infected cell & produce antibodies, neutralizing the virus before it can cause symptoms. It is as yet somewhat unclear as to why the current vaccines require boosters and fail to be very productive beyond 3-6 months. One theory is that these vaccines, while doing a fairly adequate job of inducing temporary humoral immunity, do not do as well at stimulating long term cell-mediated immunity; this may be due to the fact that the immune system is not being exposed to the entire virus. In a natural immune response, however, these T cells are stimulated and, for the vast majority of pathogens and how we have understood the immune system to work for decades now, cell-mediated immunity usually lasts a lifetime in a healthy individual."

Again, the first part is true. T-cell medicated immunity is incredibly important for a longer-lasting immunity and antibody levels are expected to decrease as exposure to antigen declines (or else our serum would be full of only antibodies from all the pathogens we've encountered throughout our life as we got old). But, the second part doesn't jive. We know vaccinated individuals have just as strong (if not stronger) T-cell response during challenge compared to "natural" infection. That data is clear from when the vaccines were FDA approved in November 2020. And again from my last paragraph above, we know the best antigens from SARS-COV-2 that stimulate the immune system are from spike protein and not other parts of the virus...the second part is all unfounded speculation that would not hold up with scientific rigor as a real hypothesis.

Why are antibody levels and vaccine boosters important, particularly when dealing with the SARS-COV-2 delta variant? It comes down to a race between how fast the virus is replicating in our bodies vs how effective or prepared the immune system is at the moment we are exposed. SARS-COV-2 is really fast and efficient at replicating! Properties of the delta variant make it even more effective than the original. If we don't have enough neutralizing antibodies around at the moment of exposure and initial replication of the virus, the virus wins out in the beginning and replicates for a while which leads to symptoms (aka "break-through" cases) -- but the human body wins in the end and eliminates the virus before serious disease is caused. Think of it like a football team taking an early 14-0 lead in the first quarter to only lose 28-14. If we have enough neutralizing antibody circulating, we can completely prevent that 14-0 lead from occurring and limit viral replication - which leads to zero symptoms and/or complications. That's why boosters are recommended for a certain group of our population. If we were dealing with a different virus with different replication patterns, maybe we wouldn't need any boosters at all. It a total supply/demand issues. Have a lot of viral particles that need to be neutralized (demand)? Then we need to have sufficient supply to cover. That supply just goes down over time and needs to be replenished/boosted to prevent symptoms from occurring and potential harmful disease.

There are small aspects of his explanation that don't jive with my understanding. Enlighten me please.




see bolded comments below each paragraph. HTH.
Derrida
How long do you want to ignore this user?
Ranger222 said:

Derrida said:


"When an individual is exposed to a respiratory pathogen, the first line of defense is IgM mucosal immunity. A vaccinated person typically does not get this immunity, because the antibodies are first encountered in the bloodstream, not external mucosal linings. This is one reason why vaccinated individuals tend to have as much antigen on their mucosal swabs as unvaccinated, previously uninfected individuals and more than a naturally immune person. Hence, they can still be vectors of disease through mucosal spread.

This paragraph is completely wrong. IgM is not the "first line of defense for mucosal immunity". That would be IgA. IgA is ~15% of total antibodies produced and present at mucosal sites...like mucus, saliva, etc. and would be the true first line of defense for a respiratory pathogen (bacteria or virus). IgA has been shown to be produced by vaccinated individuals with antibodies that neutralize SARS-COV-2. I think you're friend is mixing up the order in which these antibodies are produced by the body and the "first line of defense" thing. It is true that IgM is the first antibody produced by the body in response to an antigen, that then class switches into IgG and IgA at a later time. IgM is also typically only found in the blood due to their large size...but this is how the immune system works for everyone. The same process occurs for vaccinated vs un-vaccinated people in response to a vaccine or real virus (antigen), so I'm failing to see the point of this as its no different between populations. And the "vaccinated individuals have as much antigen" thing is weird. If two people are exposed to the same amounts of virus, of course they "have as much antigen" no matter if they are vaccinated or not. That's exposure! What matters is does that virus and virus particle then replicate in that person and can the virus be released in a way that leads to infection of another individual. We'd like to believe that vaccinated individuals do not as efficiently replicate and release virus as un-vaccinated individual, but that data is still being collected. The uninfected and naturally immune person having "less antigen" is completely bogus and would require a citation to determine where that statement comes from.

The second line of defense is humoral immunity. This is what we also know of as IgG antibody induced immunity. Antibodies are created in order to defeat the acute illness. It takes a while for the human body to ramp up those antibodies from scratch, so during that time a patient is ill. The current Covid vaccine appears to do a decent job of inducing humoral immunity (hence the lessening of symptoms upon subsequent exposure to the live virus). However, this humoral immunity is primarily targeted toward the alpha spike protein, not the other variants. Therefore, we see a lot more breakthrough infections in vaccinated people than we do in naturally immune people, because naturally immune individuals (as with traditional dead/attenuated viral vaccines) were exposed to the entirety of the virus, not just the specific alpha spike protein. This may also be one reason why forthcoming vaccines like Novavax, which use more traditional technology, are thus far proving to be more effective in trials.

This is all, in theory, true. I was very skeptical of mRNA-based vaccines when the pandemic began for this reason -- exposure to all viral proteins is better than one (spike) to mount an antibody response. However, as we have found, the mRNA vaccines are incredibly successful! The spike protein is a great antigen to make antibodies against! We got incredibly lucky in that regard. In this particular case (may not be true of all viruses / pathogens), it turns out that all we needed was the spike protein and exposure to other viral proteins doesn't really "increase" our immunity in a significant way. The best case for this point is in studies conducted in 2020 looking at the serum of patients that had been infected and recovered from SARS-COV-2 (all pre-vaccine) that determined what type of antibodies these people had. Turned out a large majority, and the best neutralizing antibodies, were all to the spike protein! There is a reason almost all monoclonal antibodies made by companies as IV treatments (like "the Regeneron") are to spike protein and not other proteins. These are the best antibodies and they all bind / recognize spike and are all naturally made/selected for by our own bodies!

The third line of defense is where our long-term immunity comes from, specifically cell-mediated immunity. Over time, circulating antibodies in the bloodstream naturally decline (which is why the argument that we don't know how long antibodies last is irrelevant - they aren't supposed to circulate forever). This is our memory T- & B-cells, killer T-cells, etc. During the first exposure, memory cells are created. Subsequent exposures to the same antigen stimulate these cells to immediately attack the antigen/infected cell & produce antibodies, neutralizing the virus before it can cause symptoms. It is as yet somewhat unclear as to why the current vaccines require boosters and fail to be very productive beyond 3-6 months. One theory is that these vaccines, while doing a fairly adequate job of inducing temporary humoral immunity, do not do as well at stimulating long term cell-mediated immunity; this may be due to the fact that the immune system is not being exposed to the entire virus. In a natural immune response, however, these T cells are stimulated and, for the vast majority of pathogens and how we have understood the immune system to work for decades now, cell-mediated immunity usually lasts a lifetime in a healthy individual."

Again, the first part is true. T-cell medicated immunity is incredibly important for a longer-lasting immunity and antibody levels are expected to decrease as exposure to antigen declines (or else our serum would be full of only antibodies from all the pathogens we've encountered throughout our life as we got old). But, the second part doesn't jive. We know vaccinated individuals have just as strong (if not stronger) T-cell response during challenge compared to "natural" infection. That data is clear from when the vaccines were FDA approved in November 2020. And again from my last paragraph above, we know the best antigens from SARS-COV-2 that stimulate the immune system are from spike protein and not other parts of the virus...the second part is all unfounded speculation that would not hold up with scientific rigor as a real hypothesis.

Why are antibody levels and vaccine boosters important, particularly when dealing with the SARS-COV-2 delta variant? It comes down to a race between how fast the virus is replicating in our bodies vs how effective or prepared the immune system is at the moment we are exposed. SARS-COV-2 is really fast and efficient at replicating! Properties of the delta variant make it even more effective than the original. If we don't have enough neutralizing antibodies around at the moment of exposure and initial replication of the virus, the virus wins out in the beginning and replicates for a while which leads to symptoms (aka "break-through" cases) -- but the human body wins in the end and eliminates the virus before serious disease is caused. Think of it like a football team taking an early 14-0 lead in the first quarter to only lose 28-14. If we have enough neutralizing antibody circulating, we can completely prevent that 14-0 lead from occurring and limit viral replication - which leads to zero symptoms and/or complications. That's why boosters are recommended for a certain group of our population. If we were dealing with a different virus with different replication patterns, maybe we wouldn't need any boosters at all. It a total supply/demand issues. Have a lot of viral particles that need to be neutralized (demand)? Then we need to have sufficient supply to cover. That supply just goes down over time and needs to be replenished/boosted to prevent symptoms from occurring and potential harmful disease.

There are small aspects of his explanation that don't jive with my understanding. Enlighten me please.




see bolded comments below each paragraph. HTH.
Thank you as that was helpful.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.